Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence

Accurate methods for cross-sectional incidence estimation are needed for HIV prevention research. The Limiting Antigen Avidity (LAg-Avidity) assay has been marketed by two vendors, Maxim Biomedical and Sedia BioSciences Corporation. Performance differences between the two versions of the assay are u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS Res Hum Retroviruses
Hauptverfasser: Schlusser, Katherine E., Konikoff, Jacob, Kirkpatrick, Allison R., Morrison, Charles, Chipato, Tsungai, Chen, Pai-Lien, Munjoma, Marshall, Eshleman, Susan H., Laeyendecker, Oliver
Format: Artigo
Sprache:Inglês
Veröffentlicht: Mary Ann Liebert, Inc. 2017
Schlagworte:
Epidemiology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467096/
https://ncbi.nlm.nih.gov/pubmed/28318310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0245
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge